|
PWP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.80808709618441E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.16210391204663E-11 |
| Normal-vs-Stage2 |
3.87809999999877E-05 |
| Normal-vs-Stage3 |
1.01380015493646E-10 |
| Normal-vs-Stage4 |
1.71840319751482E-12 |
| Stage1-vs-Stage2 |
6.169800E-01 |
| Stage1-vs-Stage3 |
3.153200E-01 |
| Stage1-vs-Stage4 |
8.961700E-03 |
| Stage2-vs-Stage3 |
2.418000E-01 |
| Stage2-vs-Stage4 |
3.246200E-02 |
| Stage3-vs-Stage4 |
1.492010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.31281660489913E-12 |
| Normal-vs-AfricanAmerican |
3.025800E-04 |
| Normal-vs-Asian |
1.69930000004648E-06 |
| Caucasian-vs-AfricanAmerican |
3.678800E-01 |
| Caucasian-vs-Asian |
4.843400E-01 |
| AfricanAmerican-vs-Asian |
7.327800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.38480379677731E-11 |
| Normal-vs-Female |
5.78348480217983E-12 |
| Male-vs-Female |
5.065600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.45209999580231E-09 |
| Normal-vs-Age(41-60Yrs) |
2.63560284707864E-11 |
| Normal-vs-Age(61-80Yrs) |
6.72699673742727E-11 |
| Normal-vs-Age(81-100Yrs) |
2.967000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.553600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.418400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.918000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.927600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.768600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.521200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.575800E-02 |
| Classical-VS-Follicular |
2.871800E-02 |
| Classical-VS-Other |
2.200800E-01 |
| Classical-VS-Normal |
1.47779999348785E-09 |
| Tall-VS-Follicular |
9.979800E-01 |
| Tall-VS-Other |
8.190200E-01 |
| Tall-VS-Normal |
1.31730000241248E-08 |
| Follicular-VS-Other |
8.641400E-01 |
| Follicular-VS-Normal |
1.07709996477467E-09 |
| Other-VS-Normal |
5.800700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.80757664181419E-13 |
| Normal-vs-N1 |
2.56572540990874E-12 |
| N0-vs-N1 |
9.670300E-02 |
|
|
